CRISPR Therapeutics Trades 48% Below Consensus as CASGEVY Revenue Climbs
CRISPR Therapeutics remains a standout in the gene-editing sector as the only firm with an approved product, yet shares trade significantly below…
CRISPR Therapeutics remains a standout in the gene-editing sector as the only firm with an approved product, yet shares trade significantly below…
Ulta Beauty CEO Kecia Steelman offloaded 2,000 shares in a routine transaction, retaining a significant stake as the retailer maintains steady growth…
Netflix and Airbnb leverage AI-driven cost efficiencies and robust revenue growth to fuel a potential doubling of their market valuations by 2030.
XRP climbs to $1.50 amid institutional adoption, yet regulatory risks and the rise of stablecoins like RLUSD temper expectations for significant future…
Verizon leads the outlook for the 2027 spectrum auction as JP Morgan analysts highlight its competitive positioning against SpaceX's Starlink and incumbent…
General Mills reaffirmed its full-year guidance despite margin pressure, focusing on a $750 million savings program and debt reduction to stabilize performance…
SThree shares gain momentum as the firm raises profit guidance to £12 million, driven by an 11% fee increase in the U.S.…
Historical analysis reveals that rising Treasury yields do not always trigger equity sell-offs, as strong economic growth and AI-driven corporate earnings can…
Nasdaq futures retreat from record highs while Micron and Sandisk shares face selling pressure as investors take profits on memory chip leaders.
Cracker Barrel stock surged 8.3% as the company beat fiscal Q4 earnings and revenue targets, while management unveiled a strategic fiscal 2027…
A $3,000 diversified portfolio across AT&T, Verizon, and Pfizer generates approximately $167 in annual passive income, providing investors with high yields and…
Nvidia's record-breaking revenue growth is tempered by rising receivables and extended payment terms, prompting concerns over the sustainability of current demand levels.